Preclinical molecule development is a crucial step in bringing groundbreaking therapies to patients. Enhancing the performance of these therapies requires rigorous understanding of their pharmacokinetic (PK) and pharmacodynamic (PD) properties. Comprehensive preclinical DMPK services offer a diverse range of analyses designed to elucidate the fate